Information was received from a healthcare provider (hcp) via a medtronic representative regarding a patient implanted with a set screw during set screw replacement/ crosslink placement at l4/5/sai for spinal canal stenosis.It was reported that the patient has had 4 operations in total.The dates of the initial and second operation are unknown.L3/4/5 olif and voyager fusion was performed.Mdt product was removed and replaced in tlif for l5/s.Tlif was performed at l5/s due to set screw backout.Ballast was used at sai.Fusion performed at l5/s and sai.During the hospitalization period of the patient, 2 set screws backed out, so a reoperation was performed.Set screw replacement and crosslink placement were performed. the event was associated with patient. there were no patient symptoms or complications as a result of this event.Reoperation occurred due to set screw backout. this procedure was a revision surgery, there was no delay in overall procedure time, there was no in-patient hospitalization or prolongation of existing hospitalization necessary.The date of implant was (b)(6) 2021 and the date of explant was (b)(6) 2021.The patient's medical history includes cerebral palsy.No further complications were reported/ anticipated.
|
H3: product analysis part# 6534530 ; lot# h5706913- visual and macroscopic examination revealed thread crest/flank damage; this damage appears to have initiated near the start of the thread and is evident around the damaged portion of the thread.Functional evaluation with a sample mas head found the set screw was still able to be fully engaged.The above observations are consistent with misalignment of the mas and set screw threads during construct assembly.H6: updated eval.Code method and eval.Code result post analysis medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|